Cargando…
Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991170/ http://dx.doi.org/10.1186/2051-1426-1-S1-P164 |
_version_ | 1782312386789638144 |
---|---|
author | Malu, Shruti Mbofung, Rina Khalili, Jahan Satani, Nikunj Forget, Marie-Andrée Haymaker, Cara Muller, Florian Bernatchez, Chantale Radvanyi, Laszlo Hwu, Patrick |
author_facet | Malu, Shruti Mbofung, Rina Khalili, Jahan Satani, Nikunj Forget, Marie-Andrée Haymaker, Cara Muller, Florian Bernatchez, Chantale Radvanyi, Laszlo Hwu, Patrick |
author_sort | Malu, Shruti |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3991170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39911702014-05-01 Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity Malu, Shruti Mbofung, Rina Khalili, Jahan Satani, Nikunj Forget, Marie-Andrée Haymaker, Cara Muller, Florian Bernatchez, Chantale Radvanyi, Laszlo Hwu, Patrick J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991170/ http://dx.doi.org/10.1186/2051-1426-1-S1-P164 Text en Copyright © 2013 Malu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Presentation Malu, Shruti Mbofung, Rina Khalili, Jahan Satani, Nikunj Forget, Marie-Andrée Haymaker, Cara Muller, Florian Bernatchez, Chantale Radvanyi, Laszlo Hwu, Patrick Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity |
title | Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity |
title_full | Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity |
title_fullStr | Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity |
title_full_unstemmed | Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity |
title_short | Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity |
title_sort | development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of t cell mediated cytotoxicity |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991170/ http://dx.doi.org/10.1186/2051-1426-1-S1-P164 |
work_keys_str_mv | AT malushruti developmentofnovelcombinationsoftargetedandimmunotherapiesbyunderstandingimmuneresistanceusingahighthroughputassayoftcellmediatedcytotoxicity AT mbofungrina developmentofnovelcombinationsoftargetedandimmunotherapiesbyunderstandingimmuneresistanceusingahighthroughputassayoftcellmediatedcytotoxicity AT khalilijahan developmentofnovelcombinationsoftargetedandimmunotherapiesbyunderstandingimmuneresistanceusingahighthroughputassayoftcellmediatedcytotoxicity AT sataninikunj developmentofnovelcombinationsoftargetedandimmunotherapiesbyunderstandingimmuneresistanceusingahighthroughputassayoftcellmediatedcytotoxicity AT forgetmarieandree developmentofnovelcombinationsoftargetedandimmunotherapiesbyunderstandingimmuneresistanceusingahighthroughputassayoftcellmediatedcytotoxicity AT haymakercara developmentofnovelcombinationsoftargetedandimmunotherapiesbyunderstandingimmuneresistanceusingahighthroughputassayoftcellmediatedcytotoxicity AT mullerflorian developmentofnovelcombinationsoftargetedandimmunotherapiesbyunderstandingimmuneresistanceusingahighthroughputassayoftcellmediatedcytotoxicity AT bernatchezchantale developmentofnovelcombinationsoftargetedandimmunotherapiesbyunderstandingimmuneresistanceusingahighthroughputassayoftcellmediatedcytotoxicity AT radvanyilaszlo developmentofnovelcombinationsoftargetedandimmunotherapiesbyunderstandingimmuneresistanceusingahighthroughputassayoftcellmediatedcytotoxicity AT hwupatrick developmentofnovelcombinationsoftargetedandimmunotherapiesbyunderstandingimmuneresistanceusingahighthroughputassayoftcellmediatedcytotoxicity |